Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoribosyl pyrophosphate synthetase-associated protein 1 (PRPSAP1) is a regulatory protein that associates with phosphoribosyl pyrophosphate synthetase (PRPS) enzymes, contributing to the assembly and negative regulation of the PRPS enzymatic complex involved in nucleotide biosynthesis[1][3]. PRPSAP1 does not possess enzymatic activity itself but modulates the activity and architecture of the PRPS complexes—primarily impacting the synthesis of 5-phosphoribose 1-diphosphate, a substrate important for purine and pyrimidine nucleotide biosynthesis[1][3]. It is widely expressed at different levels in various tissues and may play roles in cell viability by influencing PRPS complex formation and flexibility, rather than catalysis[1]. PRPSAP1 is associated with some disease states, particularly through regulatory dysfunction in nucleotide metabolism, and is noted as a gene of interest in cancer research, although it is not considered a direct therapeutic target[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoribosyl pyrophosphate synthetase-associated protein 1 (PRPSAP1).